We are live on ! Find out more
VNRX icon

VolitionRx Ltd
VNRX

25 hedge funds and large institutions have $4.99M invested in VolitionRx Ltd in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

0.07% less ownership

Funds ownership: 0.46% → 0.39% (-0.07%)

7% less funds holding

Funds holding: 27 → 25 (-2)

41% less capital invested

Capital invested by funds: $8.4M → $4.99M (-$3.42M)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
25
Holders Change
-2
Holders Change %
-7.41%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$70K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$50.5K
3
Bank of New York Mellon
Bank of New York Mellon
New York
+$44.2K
4
Bank of America
Bank of America
North Carolina
+$11.9K
5
OC
Oppenheimer & Co
New York
+$4.04K

Top Sellers

Rank Fund Capital Flow
1
KCM
Knoll Capital Management
Florida
-$916K
2
LIM
Lagoda Investment Management
New York
-$406K
3
VF
Virtu Financial
New York
-$49K
4
UBS Group
UBS Group
Switzerland
-$36.5K
5
LCM
Leisure Capital Management
California
-$14.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
LIM
1
Lagoda Investment Management
New York
$2.98M -$406K -8,522 -9%
Vanguard Group
2
Vanguard Group
Pennsylvania
$577K +$50.5K +1,061 +7%
BCM
3
Bridgeway Capital Management
Texas
$406K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$182K – – –
Morgan Stanley
5
Morgan Stanley
New York
$149K -$3.43K -72 -2%
LCM
6
Leisure Capital Management
California
$120K -$14.6K -306 -8%
CS
7
Credit Suisse
Switzerland
$118K – – –
OC
8
Oppenheimer & Co
New York
$70K +$4.04K +85 +5%
Northern Trust
9
Northern Trust
Illinois
$69K – – –
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$53K +$70K +1,470 New
Bank of New York Mellon
11
Bank of New York Mellon
New York
$52K +$44.2K +929 +180%
LTFS
12
Ladenburg Thalmann Financial Services
Florida
$37K – – –
GBA
13
Garrison Bradford & Associates
New York
$28K – – –
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$25K – – –
Creative Planning
15
Creative Planning
Kansas
$24K – – –
AG
16
Advisor Group
Arizona
$18K – – –
Bessemer Group
17
Bessemer Group
New Jersey
$18K – – –
HFM
18
Hartford Financial Management
Connecticut
$14K – – –
RE
19
RBC Europe
United Kingdom
$11.9K – – –
BlackRock
20
BlackRock
New York
$11K +$1.38K +29 +11%
Bank of America
21
Bank of America
North Carolina
$11K +$11.9K +250 +500%
Credit Agricole
22
Credit Agricole
France
$7K – – –
UBS Group
23
UBS Group
Switzerland
$6K -$36.5K -766 -82%
TRCT
24
Tower Research Capital (TRC)
New York
$3K +$3.85K +81 +1,013%
CPA
25
Cowen Prime Advisors
New York
$2K +$2.43K +51 New
1
2

VNRX Hedge Fund Activity: Q4 2018 in Review

25 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q4 2018, worth a combined $4.99M — down 41% from $8.4M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of VNRX and 2 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 6 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $70K. The largest seller was Knoll Capital Management, exiting entirely with an estimated $916K sold.

  • 25 institutional investors held VolitionRx Ltd (VNRX) as of Q4 2018, down from 27 in Q3 2018.
  • Funds reported $4.99M of VolitionRx Ltd stock for Q4 2018, down 41% quarter-over-quarter.
  • 2 funds opened new VolitionRx Ltd positions in Q4 2018 and 4 closed out, a net change of -2 holders.
  • The largest VolitionRx Ltd buyer in Q4 2018 was Susquehanna International Group, an estimated $70K added.
  • The largest VolitionRx Ltd seller in Q4 2018 was Knoll Capital Management, an estimated $916K sold.

Based on aggregated 13F filings for Q4 2018.